Rothschild & Co Asset Management US’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-9,476
| Closed | -$6.94M | – | 380 |
|
|
2018
Q2 | $6.94M | Sell |
9,476
-18,067
| -66% | -$13.2M | 0.07% | 286 |
|
|
2018
Q1 | $43.9M | Sell |
27,543
-14,276
| -34% | -$22.8M | 0.49% | 56 |
|
|
2017
Q4 | $37.5M | Sell |
41,819
-37,009
| -47% | -$33.2M | 0.4% | 93 |
|
|
2017
Q3 | $28.4M | Buy |
78,828
+3,778
| +5% | +$1.36M | 0.31% | 132 |
|
|
2017
Q2 | $22M | Buy |
75,050
+1,620
| +2% | +$475K | 0.25% | 162 |
|
|
2017
Q1 | $25.9M | Buy |
73,430
+1,533
| +2% | +$540K | 0.3% | 126 |
|
|
2016
Q4 | $13.2M | Buy |
71,897
+69,942
| +3,578% | +$12.9M | 0.17% | 212 |
|
|
2016
Q3 | $504K | Buy |
1,955
+49
| +3% | +$12.6K | 0.01% | 444 |
|
|
2016
Q2 | $407K | Buy |
+1,906
| New | +$407K | 0.01% | 479 |
|